Bioanalytical Testing Services Market by Type (Cell-based Assays; Virology Testing; Method Development, Optimization, and Validation; Serology, Immunogenicity, and Neutralizing Antibodies; Biomarker Testing; Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025
Get in-depth analysis of the COVID-19 impact on the Bioanalytical Testing Services Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Bioanalytical Testing Services Market
Request For Special Pricing[203 Pages Report] The bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth in this market is primarily attributed to the rising focus on the analytical testing of biologics and biosimilars, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design approach. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market during the forecast period.
The serology, immunogenicity, and neutralizing antibodies segment is estimated to grow at the highest CAGR in the bioanalytical testing services market, by type, in 2019
Based on the type of service, the bioanalytical testing services market is segmented into cell-based assays; virology testing; method development optimization and validation; serology, immunogenicity, and neutralizing antibodies; biomarker testing; pharmacokinetic testing; and other services (biologics characterization, extractable & leachable testing, and stability testing). The serology, immunogenicity, and neutralizing antibodies segment is estimated to grow at the highest CAGR during the forecast period. The high growth in this segment can be attributed to the high and growing utilization of serology, immunogenicity, and neutralizing antibodies in drug development procedures.
The oncology segment will continue to dominate the bioanalytical testing services applications market during the forecast period
Based on the application area, the bioanalytical testing services market is broadly categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other applications. Oncology is the largest application segment in this market, primarily due to the increasing number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide. With the increasing burden of cancer on healthcare systems worldwide, both government and private organizations are increasingly focusing on developing novel cancer therapies. This is expected to drive the demand for bioanalytical testing services in the clinical trials of cancer drugs.
Pharmaceutical and biopharmaceutical companies are the largest end users of bioanalytical testing services
Based on end user, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations. In 2019, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the bioanalytical testing services market. The large share of this segment can be attributed to the increased outsourcing of early-phase development, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate processes and products.
Asia Pacific market to witness the highest growth during the forecast period
The global bioanalytical testing services market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the presence of a large patient population (especially in China and India), increasing investments in R&D, and growth in the outsourcing of drug discovery services to Asian CROs.
Key Market Players
The prominent players operating in the bioanalytical testing services market are Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), and LGS Limited (UK).
Scope of the report
|
Report Metric |
Details |
|
Market Size Available for Years |
20182025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
20202025 |
|
Forecast Unit |
Value (USD Billion) |
|
Segments Covered |
Type, Application, and End User |
|
Geographies Covered |
|
The research report categorizes the bioanalytical testing services market into the following segments and sub-segments:
By Type
- Cell-based Assays
- Bacterial cell-based assays
- Viral cell-based assays
- Virology Testing
- In Vitro Virology Testing
- In Vivo Virology Testing
- Species-specific Viral PCR Assays
- Method Development Optimization and Validation
- Serology, Immunogenicity, and Neutralizing Antibodies
- Biomarker Testing
- Pharmacokinetic Testing
- Other Services
By Application
- Oncology
- Neurology
- Infectious Diseases
- Gastroenterology
- Cardiology
- Other Applications
By End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations
- Contract Research Organizations
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In March 2020, Eurofins launched the real-time reverse transcriptase PCR assay for the qualitative detection of SARS-CoV-2.
- In February 2020, Frontage opened a new bioanalytical laboratory in Exton, PA, through its wholly-owned subsidiary, Frontage Laboratories, Inc. The new facility includes an additional 10,000 square feet of laboratory space, which will enhance the companys bioanalytical capabilities in biomarkers, biologics, and small-molecule drug development, cell and gene therapy, and high-throughput clinical sample management.
- In January 2020, Charles River partnered with Fios Genomics (UK). This partnership assisted the firm in the sourcing and analysis of high-dimensional, multi-variant datasets associated with drug development.
- In May 2019, ICON plc acquired MeDiNova Research (UK). This acquisition was aimed at enhancing ICONs patient recruitment capabilities in EMEA and complemented its existing site network in the US (PMG Research).
Key Questions Addressed in the Report
- What are the top 10 players operating in the bioanalytical testing services market?
- What are the drivers, restraints, opportunities, and challenges impacting the market?
- What are the prevailing industry trends?
- What is the current scenario of the bioanalytical testing services market?
- How is the bioanalytical testing services market performing in different regions across the globe?
Frequently Asked Questions (FAQ):
Which type of service is leading the by type segment?
The bioanalytical testing services market is segmented broadly into cell based assays, virology testing, method development optimization and validation, serology, serology, immunogenicity & neutralizing antibodies, biomarker testing, pharmacokinetic testing and other services (biologics characterization, extractable & leachable testing and stability testing). In 2019, cell-based assays segment accounted for the largest share due to increasing utilization of cell-based assays in developing newer drugs as a result of increasing prevalence of chronic diseases.
Which is the leading end user for bioanalytical testing services market?
The end users of the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development manufacturing organizations (CDMOs) and contract research organizations (CROs). In 2019, pharmaceutical and biopharmaceutical companies accounted for the largest share of the bioanalytical testing services market. The large share of this segment can be attributed to the increased outsourcing of early phase development services, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate the process and product.
Which is the leading application of bioanalytical tests?
The application segment is broadly categorized into oncology, neurology, infectious diseases, digestive systems, cardiovascular and other application areas. In 2019, oncology accounted for the largest share of the bioanalytical testing services market. This is primarily attributed to the growing prevalence of urinary incontinence, an increasing number of surgeries, and the rising geriatric population.
Who are the key players operating in the bioanalytical testing services market?
The bioanalytical testing services market is highly competitive and fragmented. The prominent players operating in this market include Charles River (US), Medpace (US), Wuxi Apptec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings. (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), Parexel International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), LGS Limited (England).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 19)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 22)
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 30)
4 PREMIUM INSIGHTS (Page No. - 33)
4.1 BIOANALYTICAL TESTING SERVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION & COUNTRY (2019)
4.3 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: BIOANALYTICAL TESTING SERVICES MARKET
4.5 BIOANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
5 MARKET OVERVIEW (Page No. - 38)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising focus on the analytical testing of biologics and biosimilars
5.2.1.2 Increasing preference for outsourcing analytical testing
5.2.1.3 Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
5.2.1.4 Rising adoption of the Quality by Design approach
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled professionals
5.2.2.2 Pricing pressure faced by major players
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries in the Asia Pacific region
5.2.3.2 Rising demand for specialized bioanalytical testing services
5.2.4 CHALLENGES
5.2.4.1 Innovative formulations demanding a unique bioanalytical testing approach
5.2.4.2 Growing need to improve the sensitivity of bioanalytical methods
6 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE (Page No. - 45)
6.1 INTRODUCTION
6.2 CELL-BASED ASSAYS
6.2.1 BACTERIAL CELL-BASED ASSAYS
6.2.1.1 Bacterial cell-based assays segment to dominate the bioanalytical testing services market for cell-based assays
6.2.2 VIRAL CELL-BASED ASSAYS
6.2.2.1 Increasing outbreaks of viral diseases to support the growth of this market segment
6.3 VIROLOGY TESTING
6.3.1 IN VITRO VIROLOGY TESTING
6.3.1.1 Higher uptake of in vitro virology assays in the development of antiviral pharmaceuticals to drive the growth of this market segment
6.3.2 IN VIVO VIROLOGY TESTING
6.3.2.1 High utilization of in vivo assays during important production phases to drive their demand
6.3.3 SPECIES-SPECIFIC VIRAL PCR ASSAYS
6.3.3.1 Wide application of species-specific viral PCR assays in the detection of viral risks to support the growth of this market segment
6.4 METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION
6.4.1 MANDATORY REQUIREMENT BY REGULATORY AUTHORITIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.5 SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.5.1 INCREASING APPLICATIONS OF SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.5.2 BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.5.3 VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.6 BIOMARKER TESTING
6.6.1 EMPHASIS ON THE DEVELOPMENT OF PERSONALIZED MEDICINE TO DRIVE THE DEMAND FOR BIOMARKER TESTING SERVICES
6.7 PHARMACOKINETIC TESTING
6.7.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR PHARMACOKINETIC TESTING SERVICES
6.8 OTHER SERVICES
7 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION (Page No. - 62)
7.1 INTRODUCTION
7.2 ONCOLOGY
7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE BIOANALYTICAL TESTING SERVICES MARKET
7.3 NEUROLOGY
7.3.1 ROBUST PIPELINE OF DRUGS FOR CNS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
7.4 INFECTIOUS DISEASES
7.4.1 OUTBREAK OF COVID-19 TO BOOST THE GROWTH OF THIS MARKET SEGMENT
7.5 GASTROENTEROLOGY
7.5.1 RISING PREVALENCE OF CHRONIC DIGESTIVE DISORDERS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
7.6 CARDIOLOGY
7.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
7.7 OTHER APPLICATIONS
8 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER (Page No. - 73)
8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
8.2.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES ARE THE LARGEST END USERS OF BIOANALYTICAL TESTING SERVICES
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
8.3.1 CDMOS PROVIDE SERVICES SUCH AS ANALYTICAL DEVELOPMENT, FORMULATION SCREENING AND DEVELOPMENT, STABILITY STUDIES, AND PRE-CLINICAL SAFETY ASSESSMENT STUDIES
8.4 CONTRACT RESEARCH ORGANIZATIONS
8.4.1 CONTRACT RESEARCH ORGANIZATIONS ARE INCREASINGLY SUBCONTRACTING THEIR ACTIVITIES TO NICHE LABORATORIES SPECIALIZED IN PROVIDING BIOANALYTICAL TESTING SERVICES
9 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION (Page No. - 80)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US is the largest market for bioanalytical testing services in North America
9.2.2 CANADA
9.2.2.1 Increasing number of clinical trials in Canada to support market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Government support and flexible labor laws have made Germany a favorable location for clinical trials
9.3.2 FRANCE
9.3.2.1 High number of oncology clinical trials in France to drive market growth
9.3.3 UK
9.3.3.1 Investment by pharmaceutical sponsors in the UK for drug discovery services to support market growth
9.3.4 ITALY
9.3.4.1 Low drug approval time in Italy, along with the growing number of clinical trials, to drive market growth
9.3.5 SPAIN
9.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China is the largest market for bioanalytical testing services in the Asia Pacific
9.4.2 JAPAN
9.4.2.1 Rising geriatric population to drive market growth in Japan
9.4.3 INDIA
9.4.3.1 Growing pharmaceutical industry in India to drive market growth
9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTOR TO DRIVE MARKET GROWTH IN LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
10 COMPETITIVE LANDSCAPE (Page No. - 131)
10.1 INTRODUCTION
10.2 COMPETITIVE LEADERSHIP MAPPING
10.2.1 VISIONARY LEADERS
10.2.2 INNOVATORS
10.2.3 DYNAMIC DIFFERENTIATORS
10.2.4 EMERGING COMPANIES
10.3 BIOANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS
10.4 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL ASSESSMENT
10.5 COMPETITIVE SITUATIONS & TRENDS
10.5.1 SERVICE LAUNCHES (20172020)
10.5.2 EXPANSIONS (20192020)
10.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (20192020)
10.5.4 ACQUISITIONS (2019)
10.5.5 OTHER DEVELOPMENTS (2019)
11 COMPANY PROFILES (Page No. - 139)
(Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View)*
11.1 CHARLES RIVER
11.2 MEDPACE
11.3 WUXI APPTEC
11.4 EUROFINS SCIENTIFIC
11.5 IQVIA INC.
11.6 SGS SA
11.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
11.8 INTERTEK GROUP PLC
11.9 PRA HEALTH SCIENCES
11.10 SYNEOS HEALTH
11.11 ICON PLC
11.12 FRONTAGE LABS
11.13 PPD, INC.
11.14 PAREXEL INTERNATIONAL CORPORATION
11.15 ALMAC GROUP
11.16 CELERION
11.17 ALTASCIENCES
11.18 BIOAGILYTIX LABS
11.19 LOTUS LABS PVT. LTD.
11.20 LGC LIMITED
*Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 196)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES (135 Tables)
TABLE 1 ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY CONVERSIONS TO USD
TABLE 2 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
TABLE 3 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 4 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY TYPE, 20182025 (USD MILLION)
TABLE 5 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 6 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL CELL-BASED ASSAYS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 7 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL CELL-BASED ASSAYS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 8 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING, BY TYPE, 20182025 (USD MILLION)
TABLE 9 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING, BY COUNTRY, 20182025 (USD MILLION)
TABLE 10 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VITRO VIROLOGY TESTING, BY COUNTRY, 20182025 (USD MILLION)
TABLE 11 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VIVO VIROLOGY TESTING, BY COUNTRY, 20182025 (USD MILLION)
TABLE 12 BIOANALYTICAL TESTING SERVICES MARKET FOR SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 13 BIOANALYTICAL TESTING SERVICES MARKET FOR METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION, BY COUNTRY, 20182025 (USD MILLION)
TABLE 14 BIOANALYTICAL TESTING SERVICES MARKET FOR SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 20182025 (USD MILLION)
TABLE 15 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 20182025 (USD MILLION)
TABLE 16 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 20182025 (USD MILLION)
TABLE 17 BIOANALYTICAL TESTING SERVICES MARKET FOR BIOMARKER TESTING, BY COUNTRY, 20182025 (USD MILLION)
TABLE 18 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACOKINETIC TESTING, BY COUNTRY, 20182025 (USD MILLION)
TABLE 19 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER SERVICES, BY COUNTRY, 20182025 (USD MILLION)
TABLE 20 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 21 BIOANALYTICAL TESTING SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 20182025 (USD MILLION)
TABLE 22 LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2018)
TABLE 23 BIOANALYTICAL TESTING SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 20182025 (USD MILLION)
TABLE 24 BIOANALYTICAL TESTING SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 20182025 (USD MILLION)
TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 20182025 (USD MILLION)
TABLE 26 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2018)
TABLE 27 BIOANALYTICAL TESTING SERVICES MARKET FOR CARDIOLOGY, BY COUNTRY, 20182025 (USD MILLION)
TABLE 28 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 29 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 30 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 20182025 (USD MILLION)
TABLE 31 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 32 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20182025 (USD MILLION)
TABLE 33 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 34 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 35 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 37 NORTH AMERICA: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 38 NORTH AMERICA: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 39 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 40 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 41 KEY INDICATORS: US
TABLE 42 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 43 US: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 44 US: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 45 US: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 46 US: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 47 KEY INDICATORS: CANADA
TABLE 48 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019)
TABLE 49 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 50 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 51 CANADA: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 52 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 53 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 54 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 55 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 56 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 57 EUROPE: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 58 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 59 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 60 KEY INDICATORS: GERMANY
TABLE 61 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 62 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 63 GERMANY: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 64 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 65 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 66 KEY INDICATORS: FRANCE
TABLE 67 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 68 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 69 FRANCE: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 70 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 71 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 72 KEY INDICATORS: UK
TABLE 73 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 74 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 75 UK: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 76 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 77 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 78 KEY INDICATORS: ITALY
TABLE 79 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 80 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 81 ITALY: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 82 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 83 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 84 KEY INDICATORS: SPAIN
TABLE 85 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 86 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 87 SPAIN: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 88 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 89 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 90 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 91 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 92 ROE: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 93 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 94 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 95 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 96 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 97 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 98 ASIA PACIFIC: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 99 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 100 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 101 KEY INDICATORS: CHINA
TABLE 102 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 103 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 104 CHINA: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 105 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 106 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 107 KEY INDICATORS: JAPAN
TABLE 108 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 109 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 110 JAPAN: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 111 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 112 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 113 INCREASE IN THE R&D EXPENDITURE OF THE TOP 5 INDIAN PHARMACEUTICAL COMPANIES (2010 VS. 2018)
TABLE 114 KEY INDICATORS: INDIA
TABLE 115 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 116 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 117 INDIA: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 118 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 119 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 120 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 121 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 122 ROAPAC: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 123 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 124 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 125 NUMBER OF CLINICAL TRIALS IN LATINA AMERICA, BY COUNTRY (JUNE 2019)
TABLE 126 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 127 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 128 LATIN AMERICA: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 129 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 130 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: VIROLOGY TESTING MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 20182025 (USD MILLION)
LIST OF FIGURES (49 Figures)
FIGURE 1 BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 BIOANALYTICAL TESTING SERVICES MARKET: REGIONAL SNAPSHOT
FIGURE 11 RISING FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET GROWTH
FIGURE 12 ONCOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOANALYTICAL TESTING SERVICES MARKET IN 2019
FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 15 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
FIGURE 16 BIOANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 20172024
FIGURE 18 NUMBER OF REGISTERED STUDIES, 20012019
FIGURE 19 NUMBER OF PIPELINE DRUGS, BY COMPANY, 2019
FIGURE 20 GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS, 20152018
FIGURE 21 WORLDWIDE CANCER INCIDENCE AND MORTALITY (20182040)
FIGURE 22 ANNUAL DRUG APPROVALS BY CDER (20102019)
FIGURE 23 PHARMACEUTICAL R&D SPENDING, 20102018
FIGURE 24 ACTIVE PHARMACEUTICAL PIPELINE, 20012019
FIGURE 25 CHINA IS EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 26 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019)
FIGURE 27 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 28 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2019)
FIGURE 29 TOTAL R&D EXPENDITURE OF THE US PHARMACEUTICAL INDUSTRY (20102018)
FIGURE 30 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 20132017 (USD BILLION)
FIGURE 32 UK: COMMERCIAL CLINICAL TRIAL APPLICATIONS, BY PHASE, 20132017
FIGURE 33 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 34 KEY DEVELOPMENTS IN THE BIOANALYTICAL TESTING SERVICES MARKET
FIGURE 35 BIOANALYTICAL TESTING SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 36 MARKET SHARE ANALYSIS: BIOANALYTICAL TESTING SERVICES MARKET (2019)
FIGURE 37 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE BIOANALYTICAL TESTING SERVICES MARKET (2018)
FIGURE 38 CHARLES RIVER: COMPANY SNAPSHOT (2019)
FIGURE 39 MEDPACE: COMPANY SNAPSHOT (2018)
FIGURE 40 WUXI APPTEC: COMPANY SNAPSHOT (2018)
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 42 IQVIA INC.: COMPANY SNAPSHOT (2019)
FIGURE 43 SGS SA: COMPANY SNAPSHOT (2019)
FIGURE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
FIGURE 45 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2019)
FIGURE 46 PRA HEALTH SCIENCES: COMPANY SNAPSHOT (2019)
FIGURE 47 SYNEOS HEALTH: COMPANY SNAPSHOT (2019)
FIGURE 48 ICON PLC: COMPANY SNAPSHOT (2019)
FIGURE 49 FRONTAGE LABS: COMPANY SNAPSHOT (2018)
This study involved four major activities for estimating the current size of the global bioanalytical testing services market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the bioanalytical testing services market. Primary sources from the demand side include experts from hospitals and diagnostic labs and research and academic laboratories. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the bioanalytical testing services market was arrived at after data triangulation from two different approaches, as mentioned below.
Approach to calculate the revenue of different players in the bioanalytical testing services market
The size of the global bioanalytical testing services market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global bioanalytical testing services market was derived.
Approach to derive the market size and estimate market growth
The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Data Triangulation
After arriving at the overall market size-using the market size estimation processes explained above-the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Objectives of the Study
- To define, describe, and forecast the bioanalytical testing services market based on type, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
- To profile key market players and comprehensively analyze their product portfolios, market shares, and core competencies
- To track and analyze competitive developments, such as product launches, expansions, acquisitions, agreements, and collaborations in the bioanalytical testing services market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe bioanalytical testing services market
- Further breakdown of the Rest of Asia Pacific bioanalytical testing services market
Company Information
- Detailed analysis and profiling of additional market players
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Bioanalytical Testing Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Bioanalytical Testing Services Market